ScoreWhy is Astrazeneca Pharma India Ltd ?
1
High Management Efficiency with a high ROE of 19.06%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
With a growth in Operating Profit of 40.01%, the company declared Very Positive results in Dec 24
- PBT LESS OI(Q) At Rs 67.59 cr has Grown at 102.7%
- NET SALES(Q) Highest at Rs 440.29 cr
- PBDIT(Q) Highest at Rs 76.99 cr.
4
Stock is technically in a Mildly Bullish range
- Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
5
Majority shareholders : Promoters
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
7
Consistent Returns over the last 3 years
- Along with generating 54.15% returns in the last 1 year, the stock has outperformed BSE 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Astrazeneca Phar should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Astrazeneca Phar for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Astrazeneca Phar
55.8%
1.21
44.85%
SENSEX
0.45%
0.02
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.37%
EBIT Growth (5y)
15.15%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.92
Tax Ratio
26.68%
Dividend Payout Ratio
37.15%
Pledged Shares
0
Institutional Holding
8.15%
ROCE (avg)
99.35%
ROE (avg)
19.06%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
112
Industry P/E
33
Price to Book Value
28.11
EV to EBIT
102.18
EV to EBITDA
89.91
EV to Capital Employed
92.60
EV to Sales
12.05
PEG Ratio
8.09
Dividend Yield
0.30%
ROCE (Latest)
80.46%
ROE (Latest)
25.17%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
PBT LESS OI(Q)
At Rs 67.59 cr has Grown at 102.7%
NET SALES(Q)
Highest at Rs 440.29 cr
PBDIT(Q)
Highest at Rs 76.99 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 17.49%
PAT(Q)
Highest at Rs 55.48 cr.
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Astrazeneca Phar
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 67.59 cr has Grown at 102.7%
over average PBT of the previous four quarters of Rs 33.34 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 440.29 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 55.48 cr has Grown at 59.1%
over average PAT of the previous four quarters of Rs 34.87 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 76.99 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 17.49%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 67.59 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 55.48 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
